HHFNC + Clinical decision Support for Bronchiolitis

UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA
Clinical Decision Support (CDS) +1 moreN/AWaitlist AvailableLed by Christopher Horvat, MDResearch Sponsored by University of Pittsburgh

Study Summary

This trial aims to improve recovery from common pediatric respiratory illnesses, reduce costs, and show UPMC Children's Hospital's capabilities in pediatric healthcare. It will examine using CDS to improve adherence to standardized guidelines and outcomes.

Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below
Select...
Children under the age of 2 with a "Bronchiolitis WOB Score" greater than 2 will not be included.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~days from admission to death
This trial's timeline: 3 weeks for screening, Varies for treatment, and days from admission to death for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
ICU length of stay
Secondary outcome measures
90-day cost of care
Cost of hospitalization
Hospital length of stay
+5 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: HHFNC + Clinical decision SupportExperimental Treatment2 Interventions
Standardized HHFNC weaning coupled with clinical decision support consisting of electronic record embedded reminders to the clinical team to wean HHFNC
Group II: HHFNC WeaningActive Control2 Interventions
Team does not receive clinical decision support reminders to wean the HHFNC

Find a site

Who is running the clinical trial?

Beckwith FoundationUNKNOWN
1 Previous Clinical Trials
8 Total Patients Enrolled
University of PittsburghLead Sponsor
1,674 Previous Clinical Trials
16,301,760 Total Patients Enrolled
1 Trials studying Bronchiolitis
600 Patients Enrolled for Bronchiolitis
Christopher HorvatLead Sponsor
Christopher Horvat, MDPrincipal Investigator
UPMC Children's Hospital of Pittsburgh

Media Library

HHFNC + Clinical decision Support Clinical Trial Eligibility Overview. Trial Name: NCT05909566 — N/A
Bronchiolitis Research Study Groups: HHFNC + Clinical decision Support, HHFNC Weaning
Bronchiolitis Clinical Trial 2023: HHFNC + Clinical decision Support Highlights & Side Effects. Trial Name: NCT05909566 — N/A
HHFNC + Clinical decision Support 2023 Treatment Timeline for Medical Study. Trial Name: NCT05909566 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment for this trial still open at present?

"As per clinicaltrials.gov, this study is not currently seeking participants; it was posted on June 1st 2023 and last updated on the 11th of June 2023. However, there are 40 other trials actively enrolling patients at present."

Answered by AI
~132 spots leftby Apr 2026